The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex. Journal of Biological Chemistry 277(28): 25576-25582, 2002
Protein kinase C-and ras-dependent activation of c-jun gene by human papillomavirus type 11 E5a oncoprotein. Cancer Letters 95(1-2): 201-205, 1995
Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6. Journal of Virology 78(16): 8468-8476, 2004
Human papillomavirus 16 E7 oncoprotein attenuates DNA damage checkpoint control by increasing the proteolytic turnover of claspin. Cancer Research 69(17): 7022-7029, 2009
The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC. Journal of Virology 90(12): 5611-5621, 2016
The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. Journal of Virology 73(8): 6209-6219, 1999
Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue. Oncogene 19(51): 5944-5950, 2000
A Cu 2+ complex induces the aggregation of human papillomavirus oncoprotein E6 and stabilizes p53. Febs Journal 285(16): 3013-3025, 2018
Phosphorylation of oncoprotein e7 of human papillomavirus type 16 hpv16 by casein kinase ii ckii. Cell Structure and Function 15(6): 499, 1990
Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Cancer Research 68(23): 9964-9972, 2008
Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. Journal of Virology 75(9): 4467-4472, 2001
Selective activation of cervical microvascular endothelial cells by human papillomavirus 16-e7 oncoprotein. Journal of the National Cancer Institute 93(24): 1843-1851, 2001
(-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α. Cancer ChemoTherapy and Pharmacology 71(3): 713-725, 2013
Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. Journal of Virology 81(7): 3618-3626, 2007
Inhibition of kinase IKKβ suppresses cellular abnormalities induced by the human papillomavirus oncoprotein HPV 18E6. Scientific Reports 11(1): 1111, 2021